Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05804318 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05804318 · ClinicalTrials.gov record · last posted 2026-05-28

Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer

Study acronym: ARTIA-Prostate
StatusRecruiting
PhaseNot applicable
Started2023-04-13
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 28, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
This trial is a prospective, single-arm, multi-center clinical trial designed to assess whether adaptive radiotherapy with urethral sparing for low to intermediate risk localized prostate cancer will translate into a decreased rate of patient reported acute urinary side effects, as measured by the patient reported EPIC-26 questionnaire, compared with the historically reported rate for non-adaptive, non-urethral sparing prostate SBRT.

Amendment record 8 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 8 times since 2023-03-26; most recent amendment 2026-05-27. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2023-05-07
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT05804318
Lead Sponsor Varian, a Siemens Healthineers Company
Conditions Prostate Cancer
Enrollment 132 participants
Start Date 2023-04-13
Primary Completion 2026-07 (estimated)
Study Completion 2031-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-28